New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Healthcare Realty Trust Incorporated

HR

Real Estate Reit Healthcare Facilities

Healthcare Realty Trust Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 6.92% from fiscal 2024.

Revenue
−3.74%
EPS
n/m
Free cash flow
−65.2%
Total debt
+2.51%

Quarter to September 2026, against a year earlier

19.38 0.02 +0.10%

After hours trading: 19.36, down 0.10%, last trade Fri 4:01pm Eastern.

Market cap
$6.6B
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
4.95%
F-score
5/9
ROIC
2.19%
Net debt / EBITDA
0.1×
Payout ratio
—

Where the cash went Q3 FY2026, quarter to Sep 30, 2026

Free cash flow of $152.1M covered $132.4M of dividends and buybacks. Cash fell by $1.5M. Lines the picture does not name came to −$63.7M. What is a cash flow statement?

Free cash flow
$152.1M 124.4% of operating cash flow
Returned to shareholders
$132.4M 87.0% of free cash flow
Debt, net
$71.3M borrowed
Change in cash
−$1.5M over the period
Where the cash went, in millions of dollars
Operating cash flow122.3
Capital expenditures+29.8
Free cash flow152.1
Into investments, net−28.9
Dividends−82.3
Buybacks, net−50.1
Debt raised, net+71.3
Other−63.7
Change in cash−1.5
Operating cash flowCapexFree cash flow
Operating cash flow, capex and free cash flow, four quarters
Q4 FY25Q1 FY26Q2 FY26Q3 FY26
Operating cash flow$132M$53M$142M$122M
Capex$611M$27M$9.9M$30M
Free cash flow$744M$80M$152M$152M

Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.

Older periods Dec '25 Mar '26 Jun '26 Sep '26
Net Income

+8 more quarters

14.59 0.02 (43.95) (15.85)
Depreciation & Amortization
135.16 132.89 128.72 130.00
Non Cash Items (Other)
(19.69) (1.96) 46.81 23.16
Change in payables and accrued liability
— (55.54) 29.64 3.58
Change in other assets and liabilities
(5.20) (22.54) (19.03) (18.59)
Operating Cash Flow
132.34 52.88 142.19 122.29
Capital expenditures
611.41 27.20 9.94 29.84
Long-Term Investments Change (Net)
(0.65) (17.63) (0.90) (28.86)
Other investing activities
(84.28) (54.88) (16.05) (62.39)
Investing cash flow
526.48 (45.31) (7.02) (61.41)
Repayment/Issuance of Debt (Net)
(585.85) 180.69 69.05 71.26
Equity Repurchase (Common, Net)
(0.38) (102.04) (75.73) (50.10)
Dividends Paid (Total)
(84.39) (83.90) (82.24) (82.25)
Other financial activities
(5.53) (2.25) (53.48) (1.27)
Financing cash flow
(676.15) (7.50) (142.41) (62.36)
Change in Cash
(17.32) 0.06 (7.25) (1.49)
Beginning Cash
0.00 26.17 0.00 0.00
Ending Cash
(17.32) 26.24 (7.25) (1.49)
Stock Based Compensation
3.35 5.42 4.42 4.56
Dividends Paid (Common)
(84.39) (83.90) (82.24) (82.25)
Net Cash/Marketcap
0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
2.28 (78.07) 10.61 (15.01)
Investments Change (Net)
(0.65) (17.63) (0.90) (28.86)
Issuance/Purchase of Shares
(0.38) (102.04) (75.73) (50.10)

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026